Literature DB >> 23123935

Alzheimer's Disease: JNK3 as new target in AD?

Alexandra Flemming.   

Abstract

Entities:  

Year:  2012        PMID： 23123935     DOI： 10.1038/nrd3876

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  JNK3 perpetuates metabolic stress induced by Aβ peptides.

Authors:  Sung Ok Yoon; Dong Ju Park; Jae Cheon Ryu; Hatice Gulcin Ozer; Chhavy Tep; Yong Jae Shin; Tae Hee Lim; Lucia Pastorino; Ajaya J Kunwar; James C Walton; Alan H Nagahara; Kun Ping Lu; Randy J Nelson; Mark H Tuszynski; Kun Huang
Journal:  Neuron       Date:  2012-09-06       Impact factor: 17.173
  1 in total
  4 in total

1.  Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.

Authors:  Xuanzhi Zhan; Alejandro Perez; Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-01-08       Impact factor: 4.315

2.  Peptide mini-scaffold facilitates JNK3 activation in cells.

Authors:  Xuanzhi Zhan; Henriette Stoy; Tamer S Kaoud; Nicole A Perry; Qiuyan Chen; Alejandro Perez; Sylvia Els-Heindl; Jack V Slagis; Tina M Iverson; Annette G Beck-Sickinger; Eugenia V Gurevich; Kevin N Dalby; Vsevolod V Gurevich
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

3.  Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3.

Authors:  Youri Oh; Miyoung Jang; Hyunwook Cho; Songyi Yang; Daseul Im; Hyungwoo Moon; Jung-Mi Hah
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

4.  Identification of New Targets and the Virtual Screening of Lignans against Alzheimer's Disease.

Authors:  Mayara Dos Santos Maia; Gabriela Cristina Soares Rodrigues; Natália Ferreira de Sousa; Marcus Tullius Scotti; Luciana Scotti; Francisco Jaime B Mendonça-Junior
Journal:  Oxid Med Cell Longev       Date:  2020-08-15       Impact factor: 6.543
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.